AMADEUS4-1: Sarcopenia study

JRCT ID: jRCT1030220014

Registered date:08/04/2022

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: All cancer patients
• Date of first enrollment: 08/04/2022
• Target sample size: 40
• Study type: Observational

Outcome(s)

• Primary Outcome: Incidence of sarcopenia
• Secondary Outcome: ADL assessment

Key inclusion & exclusion criteria

• Age minimum: >= 16age old
• Age maximum: <= 39age old
• Gender: Both

Include criteria

1) All cancer patients scheduled for initial treatment at the study site.
2) Patients aged between 16 and 39 years at the time of consent.
3) Written consent has been obtained from the individual (if the research subject is a minor 16 years of age or older, written consent should be obtained from a surrogate in addition to the individual).

Exclude criteria

1) Patients who cannot be assessed for their ambulance status due to poor general condition.
2) Patients deemed inappropriate by the principal investigator.

Related Information

• Primary Sponsor: Iwata Shintaro